Clinical Trial Update: Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing FF/UMEC/VI vs FP/SAL plus tiotropium in inadequately controlled asthma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone Furoate/ Umeclidinium/ Vilanterol
• Fluticasone propionate/salmeterol (fluticasone propionate/salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: WITHDRAWN